Determination of flomoxef in human plasma by liquid chromatography/electrospray ionization tandem mass spectrometry. 2013

Oxana Yu Kravtsova, and Sergey A Paramonov, and Natalya I Vasilevich, and Denis N Kazyulkin, and Ekaterina Vlasova, and Michael Engsig
Bioscreening Laboratory Co. Ltd, 20 Geroev Panfilovtzev Str. Bldg 1, Moscow, 125480, Russia.

A specific, sensitive, rapid and reproducible method for the determination of flomoxef in human plasma using high-performance liquid chromatography-tandem mass spectrometry was developed and validated. Flomoxef was detected using an electrospay ionization method operated in negative-ion mode. Chromatographic separation was performed in gradient elution mode on a Luna® C18(2) column (3 μM, 20 × 4.0 mm) at a flow rate of 1 mL/min and runtime 3.5 min. The mobile phase consisted of acetonitrile and water containing 0.1% formic acid as additive. Extraction of flomoxef from plasma and precipitation of plasma proteins was performed with acetonitrile with an absolute recovery of 86.4 ± 1.6%. The calibration curve was linear with a correlation coefficient of 0.999 over the concentration range 10-5000 ng/mL and the lower limit of quantification was 10 ng/mL. The intra- and inter-day precisions were <11.8%, while the accuracy ranged from 99.6 to 109.0%. A stability study of flomoxef revealed that it could be successfully analyzed at 4 ºС over 24 h, but it was unstable in solutions at room temperature during short-term storage (4 h) and several freeze-thaw cycles.

UI MeSH Term Description Entries
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D002853 Chromatography, Liquid Chromatographic techniques in which the mobile phase is a liquid. Liquid Chromatography
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face
D016018 Least-Squares Analysis A principle of estimation in which the estimates of a set of parameters in a statistical model are those quantities minimizing the sum of squared differences between the observed values of a dependent variable and the values predicted by the model. Rietveld Refinement,Analysis, Least-Squares,Least Squares,Analyses, Least-Squares,Analysis, Least Squares,Least Squares Analysis,Least-Squares Analyses,Refinement, Rietveld
D053719 Tandem Mass Spectrometry A mass spectrometry technique using two (MS/MS) or more mass analyzers. With two in tandem, the precursor ions are mass-selected by a first mass analyzer, and focused into a collision region where they are then fragmented into product ions which are then characterized by a second mass analyzer. A variety of techniques are used to separate the compounds, ionize them, and introduce them to the first mass analyzer. For example, for in GC-MS/MS, GAS CHROMATOGRAPHY-MASS SPECTROMETRY is involved in separating relatively small compounds by GAS CHROMATOGRAPHY prior to injecting them into an ionization chamber for the mass selection. Mass Spectrometry-Mass Spectrometry,Mass Spectrometry Mass Spectrometry,Mass Spectrometry, Tandem
D021241 Spectrometry, Mass, Electrospray Ionization A mass spectrometry technique used for analysis of nonvolatile compounds such as proteins and macromolecules. The technique involves preparing electrically charged droplets from analyte molecules dissolved in solvent. The electrically charged droplets enter a vacuum chamber where the solvent is evaporated. Evaporation of solvent reduces the droplet size, thereby increasing the coulombic repulsion within the droplet. As the charged droplets get smaller, the excess charge within them causes them to disintegrate and release analyte molecules. The volatilized analyte molecules are then analyzed by mass spectrometry. ESI Mass Spectrometry,Electrospray Ionization Mass Spectrometry,Mass Spectrometry, ESI,Spectrometry, ESI Mass

Related Publications

Oxana Yu Kravtsova, and Sergey A Paramonov, and Natalya I Vasilevich, and Denis N Kazyulkin, and Ekaterina Vlasova, and Michael Engsig
March 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Oxana Yu Kravtsova, and Sergey A Paramonov, and Natalya I Vasilevich, and Denis N Kazyulkin, and Ekaterina Vlasova, and Michael Engsig
January 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Oxana Yu Kravtsova, and Sergey A Paramonov, and Natalya I Vasilevich, and Denis N Kazyulkin, and Ekaterina Vlasova, and Michael Engsig
March 2007, Journal of pharmaceutical and biomedical analysis,
Oxana Yu Kravtsova, and Sergey A Paramonov, and Natalya I Vasilevich, and Denis N Kazyulkin, and Ekaterina Vlasova, and Michael Engsig
November 2002, Journal of pharmaceutical and biomedical analysis,
Oxana Yu Kravtsova, and Sergey A Paramonov, and Natalya I Vasilevich, and Denis N Kazyulkin, and Ekaterina Vlasova, and Michael Engsig
February 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Oxana Yu Kravtsova, and Sergey A Paramonov, and Natalya I Vasilevich, and Denis N Kazyulkin, and Ekaterina Vlasova, and Michael Engsig
January 2004, Journal of pharmaceutical and biomedical analysis,
Oxana Yu Kravtsova, and Sergey A Paramonov, and Natalya I Vasilevich, and Denis N Kazyulkin, and Ekaterina Vlasova, and Michael Engsig
May 2008, Biomedical chromatography : BMC,
Oxana Yu Kravtsova, and Sergey A Paramonov, and Natalya I Vasilevich, and Denis N Kazyulkin, and Ekaterina Vlasova, and Michael Engsig
January 2006, Rapid communications in mass spectrometry : RCM,
Oxana Yu Kravtsova, and Sergey A Paramonov, and Natalya I Vasilevich, and Denis N Kazyulkin, and Ekaterina Vlasova, and Michael Engsig
August 2006, Biomedical chromatography : BMC,
Oxana Yu Kravtsova, and Sergey A Paramonov, and Natalya I Vasilevich, and Denis N Kazyulkin, and Ekaterina Vlasova, and Michael Engsig
June 2007, Journal of pharmaceutical and biomedical analysis,
Copied contents to your clipboard!